Why the study?
Does endovascular stent-graft implantation improve mid-term outcomes in patients with complicated type B aortic dissection compared to medical therapy in uncomplicated cases?
Does endovascular stent-graft implantation improve mid-term outcomes in patients with complicated type B aortic dissection compared to medical therapy in uncomplicated cases?
Endovascular stent-grafting for complicated type B aortic dissection promotes false lumen thrombosis and prevents aneurysmal dilatation better than medical therapy alone, despite early mortality risks.
Answers are grounded in this paper and cite their sources.
May support stent-grafting in complicated type B dissection; leaves open randomized confirmation of outcome benefits versus medical therapy.
OBJECTIVE: To evaluate the mid-term results of endovascular stent-grafting for type B aortic dissection, in comparison with those of standard medical therapy in uncomplicated cases. METHODS: Between January 1999 and 2004, among 56 patients (mean age 59.5+/-11.5 years) with type B aortic dissection, hypotensive medical therapy was the only treatment in 28 uncomplicated cases, (group A), while stent-graft implantation was performed in 28 patients with uncontrolled hypertension, persistent pain or evidence of dissection progression or complication (group B). In 14 cases (50%) the procedure was performed in an acute setting. Stent-grafting procedures were monitored with intraoperative trans-esophageal echocardiography and cine-angiography. CT scan and trans-esophageal echocardiography were performed before hospital discharge, at 6 and 12 months and then yearly. RESULTS: Follow-up (range 1-61 months, average 18.1+/-16.9 months) was 100% complete. In-hospital mortality was 10.7% (three patients, all belonging to Group B; P=0.24). No spinal cord injuries were observed. Early endoleak occurred in one patient (3.5%). Mid-term mortality was lower in Group B, although the difference was not significant (10.7 versus 14.3% in Group A, P=0.71). Follow-up CT scans evidenced complete thrombosis of the false lumen in 75% cases in Group B, 10.7% in Group A (P=0.0001), and an aneurismal dilatation of the descending aorta in 3.5% cases in Group B, 28.5% in Group A (P=0.02). CONCLUSIONS: Although with still considerable early mortality, endovascular stent-graft implantation is an effective option for the treatment of complicated type B aortic dissection. Endovascular treatment achieved a better mid-term fate of the descending thoracic aorta than medical therapy alone, even in patients with worse preoperative conditions.
No takes yet. Share an insight, caveat, or question.
Dialetto et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: